作者: Tzu-Hao Li , Hsien-Tzung Liao , Yi-Fan Huang , Yu-Chuan Shen , Yao-Chang Chiu
DOI: 10.1016/J.JFMA.2017.05.001
关键词:
摘要: Abstract Background/Purpose To analyze the real-world clinical practice for treatment of psoriatic arthritis (PsA) and to assess physicians' prescription, difficulties in diagnosis, therapeutic strategy, rationales biologic therapies unmet needs Taiwan. Methods We conducted a nationwide cross-sectional observational study by face-to-face depth interviews with 50 rheumatologists 30 dermatologists who took care patients PsA. Results The major procedures recognizing PsA included joint, skin nail examinations, radiographic imaging, medical history. More established diagnosis when didn't present rheumatoid factors ( p Conclusion This survey showed status quo Taiwan management including diagnostic difficulties, consideration, DMARDs selection treatment. It has indicated that interdisciplinary collaboration may further improve quality care. These results help establish new strategy develop next generation biologics.